KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) EPS (Weighted Average and Diluted) (2016 - 2025)

Pfizer (PFE) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with -$0.29 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) changed N/A to -$0.29 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.36 through Dec 2025, up 193700.0% year-over-year, with the annual reading at $1.36 for FY2025, 3.55% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.29 at Pfizer, down from $0.62 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $1.73 in Q3 2022, with the low at -$0.59 in Q4 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.64, with a median of $0.62 recorded in 2025.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 127.81% in 2023, then soared 5000.0% in 2025.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $1.43 in 2021, then rose by 5.59% to $1.51 in 2022, then plummeted by 139.07% to -$0.59 in 2023, then skyrocketed by 232.2% to $0.78 in 2024, then crashed by 137.18% to -$0.29 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.29, $0.62, and $0.51 for Q4 2025, Q3 2025, and Q2 2025 respectively.